0
Skip to Content
Health Business Group
Growth Strategy
Due Diligence for Transactions
Tech-enabled Healthcare Services
Life Sciences
Digital Health and AI
Private Equity/Investors
Case Studies
Consultants
History
Testimonials
Podcast
Press
Contact
Health Business Group
Growth Strategy
Due Diligence for Transactions
Tech-enabled Healthcare Services
Life Sciences
Digital Health and AI
Private Equity/Investors
Case Studies
Consultants
History
Testimonials
Podcast
Press
Contact
Folder: Services▾
Back
Growth Strategy
Due Diligence for Transactions
Folder: Sectors ▾
Back
Tech-enabled Healthcare Services
Life Sciences
Digital Health and AI
Private Equity/Investors
Case Studies
Folder: About ▾
Back
Consultants
History
Testimonials
Podcast
Press
Contact
Pharma, Research, Uncategorized 9/26/06 Pharma, Research, Uncategorized 9/26/06

Vaccines for non-fatal conditions

Read More
Economics, Pharma 9/22/06 Economics, Pharma 9/22/06

Citigroup doesn't think Wal-Mart price cut move is significant

Read More
Economics, Pharma 9/21/06 Economics, Pharma 9/21/06

Can Wal-Mart save the American health care system?

Read More
Patients, Pharma, Policy and politics, Uncategorized 9/21/06 Patients, Pharma, Policy and politics, Uncategorized 9/21/06

Finders keepers?

Read More
Culture, Pharma 9/13/06 Culture, Pharma 9/13/06

Will it play in Palo Alto?

Read More
Patients, Pharma, Policy and politics 4/8/05 Patients, Pharma, Policy and politics 4/8/05

I'm upset about the Bextra withdrawal

Read More
Newer Posts

SERVICES

Growth StrategyDue Diligence for Transactions

SECTORS

Tech-enabled Healthcare Services
Life Sciences

Digital Health and AI
Private Equity/Investors

ABOUT

Consultants
Case Studies
History
Testimonials

Press
Contact

101 Federal St., S. 1900 | Boston, MA 02110 | (617) 731-3182

© 2026 Health Business Group. All Rights Reserved.
Icons by Icon8